相关实验视频
Updated: Jul 20, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
案例报告:患有糖原储存疾病第九型的患者的外科治疗
Koto Kawata1,2, Hajime Otsu1,2, Qingjiang Hu1,2
1Department of Surgery, Kyushu University Beppu Hospital, Beppu, Oita, Japan.
Surgical case reports
|September 9, 2025
概括
本案例报告详细介绍了一个患有罕见的肌肉疾病 - - 糖原储存疾病型IXd (GSD型IXd) 的患者的成功外科治疗. 仔细的手术规划和监测可以防止像拉布地质溶解这样的并发症.
科学领域:
- 医学 医学 医学 医学 医学
- 遗传学 是一个遗传学.
- 手术 手术 手术 术 术
背景情况:
- 糖原储存疾病第九类 (GSD type IX) 是一种罕见的代谢障碍,由酶β激酶 (PHK) 缺乏引起,其亚型影响肝脏或肌肉.
- GSD型IXd是PHKA1突变的具体结果,导致运动不耐受性和由于糖原分解受损的潜在狂犬病.
- 这种亚型非常罕见,报告的病例很少,这突显了这项术后管理研究的新性.
研究的目的:
- 报告一个被诊断患有 IXd 类型的糖原储存疾病 (GSD 类型 IXd) 的患者的第一个已知的术后管理病例.
- 证明仔细的外科规划和监测可以导致GSD型IXd型患者的成功结果.
主要方法:
- 一名61岁的男性患有确定的PHKA1突变 (GSD型IXd) 经历了完全外皮 (TEP) inguinal hernia修复.
- 选择了手术方法,以尽量减少术后疼痛和肌肉损伤,考虑到患者的肌肉疲弱.
- 手术后的护理包括密切监测拉布地质溶解和肌球蛋白尿的迹象.
主要成果:
- 在TEP inguinal hernia修复后,该患者没有经历任何rhabdomyolysis或myoglobinuria.
- 患者在术后第7天出院,没有任何手术或疾病相关的并发症.
- 这一成功的结果强调了在接受手术的GSD型IXd患者管理的可行性.
结论:
- 通过细致的手术规划和警的监测,可以成功地进行GSD类型IXd的外科治疗.
- 轻微的GSD类型IXd症状可能导致延迟诊断,强调肌肉衰弱或肌酸激酶升高的患者需要提高意识.
- 这一案例凸显了针对罕见代谢性肌肉病变的定制外科手术期间策略的重要性.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

